Examples of bias are accumulating into an unignorable chink in healthcare AI’s armor.

The medical device giant has purchased a French spinal surgery company that currently has more than 30 digital medicine products on the market in the U.S. and Europe.

A new AI tool can accurately separate the patients who would do better getting restorative sleep till morning from those who, due to unstable condition, really need their vital signs checked overnight.

The COVID crisis has given AI a chance to shine for medical researchers this year—and shine it has, judging by one prominent center’s experience.

A healthcare startup whose AI-powered symptom checker lets users check symptoms against other patients’ experiences has begun a partnership with Mayo Clinic and raised a fresh $42 million to advance its telehealth platform.  

A new company called DeliverHealth Solutions is forming to service clients of Nuance’s HIM transcription and EHR go-live businesses.

The COVID crisis will spur leaders of life sciences companies around the world to focus on longstanding pain points that AI could help alleviate. And the execs are looking to put their money where their responses are.

When it comes to predicting an individual’s risk of suffering a heart attack or stroke over the next 10 years, machine learning models are no more consistent than traditional statistical techniques.